Summary:
Click image to enlargeLocal researchers are evaluating the safety and effectiveness of a new investigational treatment for adults with IgA Nephropathy.
Qualified Participants Must:
• Have been diagnosed with IgA Nephropathy within the last 8 years
•
Be between the ages of 18 and 70
Qualified Participants May Receive:
Compensation for study visits including blood draws, drug administrations, travel and meal expenses is available. Additionally, this trial offers a home healthcare service so patients will have the option for most study visits and drug administration to be conducted at home as well as a courier service to facilitate at home collection of urine samples.